| Bioactivity | INSCoV-600K(1) is a potent inhibitor of Mpro (3CLpro). Proteases (PL pro and 3CL pro) are involved with transcription and replication of the virus. INSCoV-600K(1) has the potential for the research of SARS-CoV-2 infection (extracted from patent WO2021219089A1)[1]. |
| Name | INSCoV-600K(1) |
| CAS | 2735704-15-9 |
| Formula | C23H22ClF2N5O2S |
| Molar Mass | 505.97 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Aleksandrs Zavoronkovs, et al. Sars-cov-2 inhibitors having covalent modifications for treating coronavirus infections. Patent WO2021219089A1. |
INSCoV-600K(1)
CAS: 2735704-15-9 F: C23H22ClF2N5O2S W: 505.97
INSCoV-600K(1) is a potent inhibitor of Mpro (3CLpro). Proteases (PL pro and 3CL pro) are involved with transcription an
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.